Nowadays, there are many concerns regarding the high degree of contaminated sites around the world. Occurrence of arsenic in groundwater and drinking water in concentrations that exceed the tolerance limit (0.01mg L−1) is a global problem, and poses an ever-increasing degree of health hazard. Our project aims to find an efficient solution for arsenic removal from contaminated waters. New cetyltrimethylammonium bromide coated iron oxide nanoparticles (FexOy-CTAB) for arsenic removal from water will be realized. Batch experiments will be carried out in order to assess the efficiency of FexOy-CTAB nanoparticles in removing arsenic ions from contaminated waters. Another goal of this project is to assess the toxicity of arsenic towards animal vital organs using in vivo studies. Our research will be focused on the study of arsenic ions adsorption by FexOy-CTAB nanoparticles from aqueous media.
Moreover, complex studies regarding the adsorption properties of arsenic on FexOy-CTAB nanoparticles which represent a novelty in the field will be conducted. Furthermore, the in vivo studies regarding arsenic toxicity on rat’s vital organs will have a great impact and will contribute with new relevant information in understanding the pathobiology of arsenic-induced diseases and will better define the toxicological implications of arsenic presence in various organ systems.
Having complex information regarding arsenic toxicity is critical for understanding the magnitude of health effects associated with arsenic exposure throughout the world. FEBIOREMOVE will provide the first comprehensive integrated research on synthesized nanoparticles for the removal of arsenic ions from contaminated drinking water and the accomplishment of the project’s objectives will lead to important advances regarding the understanding of arsenic adsorption mechanism from contaminated water by FexOy-CTAB powders.
Starting date: 23.10.2020
Ending date: 22.10.2022
Duration: 24 months